Tracy Rockney is a respected regulatory leader with more than 20 years of experience in the pharmaceutical industry. Tracy is the co-founder of OneSource Regulatory, a regulatory consulting and technology company specializing in regulatory strategy, advertising and promotion, and drug product labeling. Her senior regulatory management experience included her role as Vice President, Regulatory Affairs, Global Labeling, Advertising & Promotion, Regulatory Policy & Intelligence at AbbVie (formerly Abbott Pharmaceuticals), Senior Director, Global Regulatory Affairs at Shire Pharmaceuticals, Director, Regulatory Affairs at Wyeth, and Director, Global Regulatory Strategy at Pfizer. Tracy received her Juris Doctor from Washburn University School of Law, and her Bachelor of Arts from the University at Albany, State University of New York, Rockefeller College of Public Affairs & Policy.

Tracy is a board advisor for Daylan Pharmaceuticals, a start-up company conducting ophthalmology research, and a board advisor for Doctor Evidence, a specialty software platform and services company that transforms clinical studies, drug labeling and epidemiological databases into reusable dynamic relational databases.  Tracy is currently a steering committee member on the DIA.HBA Leadership Project which was formed by the Drug Information Association (DIA) and the Healthcare Businesswomen’s Association (HBA) to advance the careers of women in regulatory, medical, legal and compliance.  She was a member of the FDLI planning committee for the 2012 Advertising & Promotion conference.